FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Intal Capsule Not Withdrawn for S&E

[ Price : $8.95]

Federal Register Notice: FDA determines that Intal Inhalation Capsule, 20 mg was not withdrawn from sale for reasons of safety or ...

Paraflex Not Withdrawn for S&E

[ Price : $8.95]

Federal Register Notice: FDA determines that Paraflex tablets, 250 mg were not withdrawn from sale for reasons of safety or effect...

Potassium Citrate Not Withdrawn for S&E

[ Price : $8.95]

Federal Register Notice: FDA determines that Nova-K LLCs potassium citrate, 10 mEq/packet and 20 mEq/packet was not withdrawn for ...

CDER MAPP on Clearing Articles, Speeches

[ Price : $8.95]

CDER issues a MAPP outlining policies for internal clearing of articles, speeches, and other communications written by Center empl...

Reps To Introduce Mobile Medical Apps Bill

[ Price : $8.95]

A bipartisan group of six House members say they will introduce legislation to limit FDA regulation of mobile medical apps to high...

Panel to Discuss Cochlear Implant System

[ Price : $8.95]

Federal Register Notice: FDAs Ear, Nose and Throat Devices Panel will meet 11/8 to discuss a Cochlear Americas PMA for the Nucleus...

Guidance on Heptatitis C Virus Drugs

[ Price : $8.95]

Federal Register Notice: FDA releases a draft guidance: Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Dr...

ICH Elemental Impurities Guidance

[ Price : $8.95]

Federal Register Notice: FDA releases an ICH draft guidance: Elemental Impurities.

Public Citizen Challenges Change in Trial Subject Protection Guidance

[ Price : $8.95]

Public Citizen protests a HHS change in guidance on the remuneration of human clinical trial subjects.

Guidance on Acute Bacterial Skin and Skin Structure Infections

[ Price : $8.95]

Federal Register Notice: FDA releases a guidance: Acute Bacterial Skin and Skin Structure Infections Developing Drugs for Treating...